---
title: | Oncology
description: Oncology |
---

[![HUB Organoids](https://blog.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "HUB Organoids")](https://huborganoids.nl/)

![merk-m-logo-blue](https://blog.huborganoids.nl/hs-fs/hubfs/merk-m-logo-blue.png?width=728&height=225&name=merk-m-logo-blue.png)

- [services](https://huborganoids.nl/services) 
    - [services overview](https://www.huborganoids.nl/services-overview/)
    - [drug screening](https://www.huborganoids.nl/services/hub-drug-screening/)
    - [model and assay development](https://www.huborganoids.nl/services/)
    - [clinical trials in a dish](https://www.huborganoids.nl/hub-organoid-clinical-trial-in-a-dish/)
- [Technology](https://huborganoids.nl/hub-technology)
- [Company](https://huborganoids.nl/about) 
    - [about us](https://huborganoids.nl/about)
    - [Careers](https://huborganoids.nl/careers)
    - [events](https://www.huborganoids.nl/meet-us/)
    - [latest news](https://www.huborganoids.nl/news-insights-2/)
- [Resources](https://huborganoids.nl/resources/)
- [Blog](https://blog.huborganoids.nl)
- [license program](https://www.huborganoids.nl/licenses/)
- [Contact](https://resources.huborganoids.nl/contact-hub)

[discover organoid services](https://www.huborganoids.nl/services-overview/)

- [services](https://huborganoids.nl/services) 
    - [services overview](https://www.huborganoids.nl/services-overview/)
    - [drug screening](https://www.huborganoids.nl/services/hub-drug-screening/)
    - [model and assay development](https://www.huborganoids.nl/services/)
    - [clinical trials in a dish](https://www.huborganoids.nl/hub-organoid-clinical-trial-in-a-dish/)
- [Technology](https://huborganoids.nl/hub-technology)
- [Company](https://huborganoids.nl/about) 
    - [about us](https://huborganoids.nl/about)
    - [Careers](https://huborganoids.nl/careers)
    - [events](https://www.huborganoids.nl/meet-us/)
    - [latest news](https://www.huborganoids.nl/news-insights-2/)
- [Resources](https://huborganoids.nl/resources/)
- [Blog](https://blog.huborganoids.nl)
- [license program](https://www.huborganoids.nl/licenses/)
- [Contact](https://resources.huborganoids.nl/contact-hub)

# HUB's blog

![Ask the experts: Revolutionizing Oncology Drug Development with Organoid Technology](https://blog.huborganoids.nl/hubfs/assets2024/ask-the-expert-robert.jpg)

### [Ask the experts: Revolutionizing Oncology Drug Development with Organoid Technology](https://blog.huborganoids.nl/ask-the-experts-potential-of-organoids-in-oncology-research)

Published by HUB Organoids on May 7, 2024

This "Ask the Experts" feature delves into the pressing inquiries regarding the application of patient-derived organoid technology in cancer research. Dr. Robert Vries, our CEO, extensively discusses the implications of the FDA Modernization Act 2.0, the integration of organoids in the development ...

[read more](https://blog.huborganoids.nl/ask-the-experts-potential-of-organoids-in-oncology-research)

![A beginner’s guide to Inflammatory Bowel Diseases (IBD)](https://blog.huborganoids.nl/hubfs/inflammatory-bowel-disease-organoids-1.jpg)

### [A beginner’s guide to Inflammatory Bowel Diseases (IBD)](https://blog.huborganoids.nl/inflammatory-bowel-disease-organoids)

Published by HUB Organoids on Feb 26, 2024

Inflammatory Bowel Disease (IBD) is a complex condition that affects ...

[read more](https://blog.huborganoids.nl/inflammatory-bowel-disease-organoids)

![Decoding adult stem cells: exploring the hallmarks of stemness](https://blog.huborganoids.nl/hubfs/SocialMedia-Blog-decoding-adult-stem-cells%20(1).jpg)

### [Decoding adult stem cells: exploring the hallmarks of stemness](https://blog.huborganoids.nl/the-six-hallmarks-of-adult-stem-cells)

Published by HUB Organoids on Feb 19, 2024

Discover the 6 hallmarks of stemness in adult tissue Mammalian organ ...

[read more](https://blog.huborganoids.nl/the-six-hallmarks-of-adult-stem-cells)

![Challenges in preclinical modeling of cancer immunity](https://blog.huborganoids.nl/hubfs/cancer-immunity.jpg)

### [Challenges in preclinical modeling of cancer immunity](https://blog.huborganoids.nl/challenges-in-preclinical-modeling-of-cancer-immunity)

Published by HUB Organoids on Nov 1, 2022

Learn how to select the right model for your immunotherapy ...

[read more](https://blog.huborganoids.nl/challenges-in-preclinical-modeling-of-cancer-immunity)

![Ask the experts - organoids for oncology studies](https://blog.huborganoids.nl/hubfs/Copy%20of%20HUB%20News%20(21).png)

### [Ask the experts - organoids for oncology studies](https://blog.huborganoids.nl/ask-the-experts-organoids-for-oncology)

Published by Federica Parisi, PhD on Sept 9, 2021

In the first post from our "Ask the experts" series we have answered ...

[read more](https://blog.huborganoids.nl/ask-the-experts-organoids-for-oncology)

![HUB Organoids](https://blog.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "HUB Organoids")

[Privacy Policy](https://huborganoids.nl/privacy-policy)

<https://www.linkedin.com/company/huborganoids/>

HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany

***FOR RESEARCH USE ONLY.**  Unless otherwise stated in our catalog or other company documentation  
 accompanying the product(s), our products are intended for research use only and are not to be used   
 for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro   
 diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to   
humans or animals.*